This bill aims to improve access to substance use disorder treatment in New Jersey by mandating Medicaid coverage for services provided by community-based organizations, which are defined as organizations licensed by the Department of Health. It introduces new definitions and standards for medication units associated with opioid treatment programs, allowing them to offer services such as intake assessments, medication-assisted treatment, and telecounseling. The legislation emphasizes harm reduction services and individualized treatment plans, ensuring that patients cannot be denied treatment solely based on their refusal of counseling or missed doses, unless specific conditions are met. Additionally, the bill removes outdated requirements regarding the location of treatment centers in relation to schools and allows for the establishment of medication units under certain conditions.

Furthermore, the bill streamlines the licensure process for substance use disorder treatment centers and requires community-based organizations to meet specific standards to receive Medicaid reimbursement. It outlines operational guidelines for opioid treatment programs, including not requiring a pharmacist on staff and limiting mandatory drug screenings for patients. The bill mandates the establishment of licensure standards for community-based organizations and requires the Commissioner of Health to provide training and technical assistance to help these organizations comply with Medicaid enrollment standards. Overall, the legislation seeks to enhance the quality and accessibility of substance use disorder services in the state.

Statutes affected:
Introduced: 26:2H-11.1, 30:4D-6